ABSI vs AGIO Stock Comparison

AGIO currently leads ABSI in this stock comparison, with AIQ scores of 56 vs 53. The clearest difference is quality, while ABSI has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 3 points
ABSI
Healthcare
vs
AGIO
Healthcare
ABSI
Absci Corporation
Price
$8.45
Day move
-7.5%
AIQ Score
53/100
Best edge
Momentum
Sector
Healthcare
AGIO
Agios Pharmaceuticals, Inc.
Leads
Price
$31.59
Day move
-0.54%
AIQ Score
56/100
Best edge
Quality
Sector
Healthcare

What is the main difference between ABSI and AGIO?

AGIO leads the current stock comparison as Agios Pharmaceuticals, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Absci Corporation vs Agios Pharmaceuticals, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

AGIO leads

AGIO leads by 3 AIQ points, primarily on Quality and Risk Resilience, having only recently taken the lead back from ABSI. Wall Street currently favors ABSI on target upside.

Fragile: 2 of 5 evidence groups support AGIO, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 2 of 5Comparison trend: Reversed
ABSI

Absci Corporation

AIQ Score
53/100
AIQ Edge Score
9/10
AGIO

Agios Pharmaceuticals, Inc.

Leads
AIQ Score
56/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors AGIO over ABSI, 56 versus 53 as of Nov 15, 2026. AGIO's advantage is driven primarily by stronger quality and risk resilience, while ABSI holds the stronger momentum profile. AGIO also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ABSI. 2 of 5 covered evidence groups favor AGIO today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. AGIO lead: Reversed — ABSI led by 4 AIQ points 30 sessions ago; AGIO now leads by 3.

Compare Absci Corporation and Agios Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ABSI
-31.5%
AGIO
-20.4%

Price return comparison

Growth of $10,000, price only

ABSI $6,848 · AGIO $7,963

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ABSI and AGIO against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ABSI advantage
0
AGIO advantage
  • Quality26 vs 58
    AGIO +32
  • Momentum85 vs 61
    ABSI +24
  • Risk Resilience30 vs 47
    AGIO +17

2 of 5 evidence groups favor AGIO. AGIO’s edge is concentrated in quality and risk resilience; ABSI keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ABSI0 AIQ

Largest factor move: Quality -2, not enough on its own to move the overall score.

New signals

  • TSI Bearish Crossover — bearish, momentum, short horizon
AGIO0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.30x)

AGIO's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — ABSI and AGIO both carry a full feed there.

The central trade-off

AGIO (Agios Pharmaceuticals, Inc.): the stronger current systematic profile, led by quality and risk resilience.

ABSI (Absci Corporation): the counter-case, on momentum, technicals, analyst expectations — but at materially higher volatility, 126.6% against 96.3%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AGIO

AGIO on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AGIO

AGIO on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

ABSI

ABSI on the Momentum factor, by 24 points.

Lower downside

AGIO

AGIO on Risk Resilience, by 17 points.

Analyst upside

ABSI

ABSI on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors AGIO, analyst targets favor ABSI. That disagreement is the most useful thing on this page.

MeasureABSIAGIONote
Implied upside to target+71.6%+10.8%ABSI has more room
Target dispersion+6.9%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1210Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor AGIO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven53 vs 56
FundamentalsAGIOon balancerevenue growth -4.4% vs 23.8%; EPS growth 9.5% vs 35.5%; TTM ROE -15.2% vs -6.6%; gross margin -26.5% vs 91.9%; operating margin -91.6% vs -297.7% — AGIO takes 4 of 5 decided legs, not all of them
ValuationNot coveredNot covered
TechnicalsABSIPrice vs 50-day -12.5% vs -4.5%; vs 200-day 23.7% vs -0.8%
Risk ResilienceAGIORisk Resilience 30 vs 47
Analyst expectationsABSITarget upside 71.6% vs 10.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABSI and AGIO and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AGIO.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

AGIO lead: Reversed — ABSI led by 4 AIQ points 30 sessions ago; AGIO now leads by 3.

May 27ABSI leads above the line · AGIO leads belowNov 13
Today
AGIO +3
53 vs 56
7 sessions ago
AGIO +2
55 vs 57
30 sessions ago
ABSI +4
53 vs 49
90 sessions ago
AGIO +1
57 vs 58

The lead changed hands 3 times in this window, most recently on Oct 19 when AGIO moved ahead of ABSI.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ABSIConflicted

2 bullish / 3 bearish / 1 neutral, conflicted

Only ABSI

  • Accumulation Pattern — bullish, volume, medium horizon (1.30x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • TSI Bearish Crossover — bearish, momentum, short horizon
AGIOConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only AGIO

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.30x)

Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Beta Spike Warning.

AGIO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ABSINo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -7.5%, AIQ 0 points).

AGIONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.54%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ABSI closes the Quality gap — currently 32 points behind, the largest single contributor to AGIO's edge.
  2. 2ABSI's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3AGIO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AGIO leads on balance
MetricABSIAGIO
Revenue growth (YoY)-4.4%23.8%
EPS growth (YoY)9.5%35.5%
Gross margin-26.5%91.9%
Operating margin-91.6%-297.7%
Return on equity (TTM)-15.2%-6.6%
Debt to equity0.020.03

Performance

ABSI leads 4 of 6 windows
MetricABSIAGIO
1 week (5 sessions)-16.9%7.4%
1 month (20 sessions)2.4%0.9%
3 months (63 sessions)-8.5%-6.1%
6 months (126 sessions)64.7%12.1%
Year to date142.1%16.1%
1 year (252 sessions)148.5%-27.6%

Technicals

ABSI has the stronger structure
MetricABSIAGIO
RSI (14)4246.3
ADX (14)13.820.6
Price vs 50-day-12.5%-4.5%
Price vs 200-day23.7%-0.8%
Volatility (1M, annualized)126.6%96.3%

Risk

AGIO is the more resilient
MetricABSIAGIO
Beta3.280.93
Sharpe ratio1.580.07
Sortino ratio2.740.08
Max drawdown-42.8%-50.9%
Current drawdown-30.2%-30.6%
Annualized volatility104.2%80%
Value at risk (95%)-8.2%-3.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ABSI or AGIO?

On the Algovestiq AIQ Score, AGIO is the stronger of the two as of Nov 15, 2026, scoring 56 against ABSI's 53. The edge comes from quality and risk resilience. ABSI is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ABSI or AGIO the better buy right now?

AGIO carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.

Why does the AIQ Score favor AGIO over ABSI?

The composite weights Quality, Value, Momentum and Risk Resilience. AGIO leads Quality by 32 points; ABSI leads Momentum by 24 points; AGIO leads Risk Resilience by 17 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ABSI or AGIO?

Analyst price targets imply +71.6% upside for ABSI and +10.8% for AGIO, so the Street currently favors ABSI. That points the opposite way to the AIQ Score, which favors AGIO. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ABSI or AGIO?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ABSI or AGIO?

AGIO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ABSI or AGIO?

ABSI on the Momentum factor, by 24 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ABSI or AGIO?

AGIO is the more resilient of the two, so the other name carries the higher downside risk. AGIO on Risk Resilience, by 17 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ABSI more profitable than AGIO?

The profitability evidence is mixed: gross margin -26.5% vs 91.9%; operating margin -91.6% vs -297.7%; ttm roe -15.2% vs -6.6%. ABSI leads on one measure and AGIO on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is AGIO's lead over ABSI getting stronger or weaker?

AGIO lead: Reversed — ABSI led by 4 AIQ points 30 sessions ago; AGIO now leads by 3. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-10-19, when AGIO moved ahead of ABSI.

What would change the ABSI vs AGIO verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ABSI closes the Quality gap — currently 32 points behind, the largest single contributor to AGIO's edge; ABSI's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; AGIO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ABSI and AGIO?

ABSI: 2 bullish / 3 bearish / 1 neutral, conflicted. AGIO: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ABSI is Golden Cross Active (bullish, long horizon). On AGIO it is Golden Cross Active (bullish, long horizon).

Compare ABSI and AGIO with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.